# PharmaCo360 Controlled Package Generation Execution Release Authorization Hold Ledger

## Phase 17.7 Control Objective

This ledger records the controlled hold position before any package generation execution release authorization can be considered for PharmaCo360.

The purpose of this phase is to confirm that execution release authorization remains blocked until all required owners, evidence, exception reviews, and explicit operator approvals are documented.

## Current Release Authorization Status

The system remains in controlled release authorization hold status.

No package archive was created.

No package generation was executed.

No checksum was generated.

No approval execution occurred.

No package command was released.

No final execution authorization was executed.

No execution decision was released.

No execution approval closure was released.

No execution release readiness was released.

No execution readiness sign-off was released.

No final release gate was released.

No operator release approval was released.

No package upload occurred.

No cPanel execution occurred.

No live deployment occurred.

No production file copy occurred.

No migration was executed.

No dependency change occurred.

No backend product change occurred.

No frontend product change occurred.

No data mutation occurred.

## Mandatory Release Authorization Hold Requirements

| Requirement | Status | Evidence Placeholder | Owner Placeholder | Notes |
|---|---:|---|---|---|
| Release authorization owner identified | Hold | Pending owner confirmation | Pending | Required before any execution release |
| Operator release approval reviewed | Hold | Pending signed review | Pending | Must reference Phase 17.6 evidence |
| Final release gate reviewed | Hold | Pending signed review | Pending | Must reference Phase 17.5 evidence |
| Readiness sign-off reviewed | Hold | Pending signed review | Pending | Must reference Phase 17.4 evidence |
| Release readiness evidence reviewed | Hold | Pending signed review | Pending | Must reference Phase 17.3 evidence |
| Approval closure reviewed | Hold | Pending signed review | Pending | Must reference Phase 17.2 evidence |
| Execution decision hold reviewed | Hold | Pending signed review | Pending | Must reference Phase 17.1 evidence |
| Final execution authorization packet reviewed | Hold | Pending signed review | Pending | Must reference Phase 17.0 evidence |
| Package generation command release hold reviewed | Hold | Pending signed review | Pending | Must reference Phase 16.9 evidence |
| Execution preflight evidence reviewed | Hold | Pending signed review | Pending | Must reference Phase 16.8 evidence |
| Authorization release ledger reviewed | Hold | Pending signed review | Pending | Must reference Phase 16.7 evidence |
| Package generation readiness lock reviewed | Hold | Pending signed review | Pending | Must reference Phase 16.6 evidence |

## Stop Conditions

Package generation execution release authorization must remain blocked if any of the following apply:

1. Any required owner is missing.
2. Any required evidence placeholder is incomplete.
3. Any exception is unresolved.
4. Any protected runtime, environment, backup, package, or production artifact is tracked.
5. Any validation guardrail fails.
6. Any package command is introduced without explicit authorization.
7. Any cPanel or production action is introduced without explicit authorization.

## Release Authorization Hold Decision

Decision: HOLD.

The PharmaCo360 package generation execution release authorization remains blocked.

This document does not approve package generation.

This document does not approve deployment.

This document does not approve production upload.

This document does not approve cPanel execution.

This document does not approve live release.
